[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-obstructive-pulmoriary-disease-copd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-obstructive-pulmoriary-disease-copd":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,47],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":41,"leadSponsor":43,"locationsCount":46},"100569250","clinical-study-on-the-treatment-of-chronic-airway-diseases-asthma-chronic-obstructive-pulmonary-disease-with-shu-fei-tie-100569250",false,"NCT06691802","Clinical Study on the Treatment of Chronic Airway Diseases (Asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie","Clinical Study on Reducing Recurrent Attacks of Chronic Airway Diseases (asthma, Chronic Obstructive Pulmonary Disease) with Shu Fei Tie Based on \"winter Disease Being Cared in Summer\"","Inclusion Criteria:\n\n* Meets the diagnostic criteria for asthma\u002FCOPD(Group E in the GOLD classification); ② Age range from18 years to 80 years(asthma) and 40 yesrs to 80 years(COPD);\n\n  * The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.\n\nExclusion Criteria:\n\n* Patients with other pulmonary diseases (lung abscess, pulmonary interstitial fibrosis, active pulmonary tuberculosis, bronchiectasis，etc);\n\n  * Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina, acute myocardial infarction, heart grade 3 or above, stroke, cerebral hemorrhage, etc.);\n\n    * Patients with severe liver diseases (liver cirrhosis, portal hypertension, and caused by esophageal and gastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.);\n\n      * Patients with impaired consciousness or various illnesses who cannot communicate normally; ⑤Pregnant and lactating women; ⑥Patients who are participating in other clinical trials within one month prior to enrollment; ⑦Patients who have received acupuncture or other traditional Chinese medicine external treatments within the past year; ⑧ Patients who are allergic to external patches","ALL","18 Years","80 Years",{"count":20,"type":21},2312,"ESTIMATED","INTERVENTIONAL",[24],"NA","Conduct a multi-center, large-sample, randomized controlled clinical study of \"winter disease being cared in summer\" with Shu Fei Tie prevent recurrence of Asthma and COPD, scientifically evaluate the clinical efficacy and safety of Shu Fei Tie in reducing the recurrence of chronic airway diseases, identify target population, clarify the mechanism of efficacy, and establish a prevention and treatment technology plan for Shu Fei Tie to reduce the recurrence of chronic airway diseases.",[27,28],"Chronic Obstructive Pulmoriary Disease (COPD)","Asthma",[30,28,31,32,33],"Chronic Obstructive Pulmoriary Disease","Shu Fei Tie","Winter disease being cared in summer","Randomized Controlled Trial","NOT_YET_RECRUITING","2024-11-14",{"date":37,"type":38},"2024-11-15","ACTUAL",{"date":40,"type":21},"2024-12",{"date":42,"type":21},"2028-07",{"name":44,"class":45},"Henan University of Traditional Chinese Medicine","OTHER",1,{"id":48,"slug":49,"hasResults":11,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":4,"eligibilityCriteria":53,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":4,"briefSummary":57,"conditions":58,"keywords":60,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":46},"100560481","respiratory-disease-cohort-studies-of-chinese-medicine-for-copdresearch-copd-100560481","NCT06577701","Respiratory Disease Cohort Studies of Chinese Medicine for COPD(RESEARCH-COPD)","Respiratory Disease Cohort Studies of Chinese Medicine for Chronic Obstructive Pulmoriary Disease (RESEARCH-COPD)","Inclusion Criteria:\n\n* Meets diagnostic criteria for chronic obstructive pulmonary disease (COPD) or preserved ratio impaired spirometry (PRISm).\n* Age ranges from 18 years to 80 years.\n* The investigators agreed to participate in this clinical study by voluntarily signing an informed consent form.\n\nExclusion Criteria:\n\n* Patients with delirium, dementia, various mental illnesses.\n* Pregnant and planned pregnant or lactating women.\n* Patients with other serious systemic diseases.\n* Patients who, in the opinion of the investigator, are not suitable for participation in this study.",{"count":55,"type":21},10000,"OBSERVATIONAL","This study will establish a registration research platform, a clinical research database and a biospecimen bank for the prevention and treatment of COPD with Chinese medicine. Based on the COPD registry database, a cohort of Chinese medicine for COPD prevention and treatment will be established.",[27,59],"Preserved Ratio Impaired Spirometry (PRISM)",[27,59,61,62,63,64],"Complication (medicine)","Traditional Chinese Medicine","Registration","Cohort study","2024-09-03",{"date":67,"type":38},"2024-09-19",{"date":69,"type":21},"2024-10-01",{"date":71,"type":21},"2027-10-30",{"name":44,"class":45}]